Jisun Hwang1, Sang Won Jo2, Eun Byul Kwon3, Seun Ah Lee1, Suk-Ki Chang1. 1. Department of Radiology, Dongtan Sacred Heart Hospital, Hallym University Medical Center, 7, Keunjaebong-gil, Hwaseong-si, Gyeonggi-do, 18450, Republic of Korea. 2. Department of Radiology, Dongtan Sacred Heart Hospital, Hallym University Medical Center, 7, Keunjaebong-gil, Hwaseong-si, Gyeonggi-do, 18450, Republic of Korea. cjinas@gmail.com. 3. Department of Pediatrics, Dongtan Sacred Heart Hospital, Hallym University Medical Center, 7, Keunjaebong-gil, Hwaseong-si, Gyeonggi-do, 18450, Republic of Korea.
Abstract
PURPOSE: To verify and integrate the prevalence and phenotype of abnormalities in the sellar region in patients with growth hormone deficiency (GHD) using MRI data. METHODS: We searched PubMed and EMBASE up to December 14, 2020. The inclusion criteria were as follows: (1) pediatric patients diagnosed with nonacquired GHD and (2) detailed data sufficient to assess the proportion of sellar and parasellar abnormalities on brain MRI scans. Finally, thirty-two studies with 39,060 children (mean or median age, 3.4-14.1 years) were included. The number and type of MRI findings from all included studies were pooled by two authors. The heterogeneity across studies was evaluated with the Q test or the inconsistency index (I2) statistic. Subgroup analyses were performed according to the type of GHD (isolated GHD [IGHD] vs. multiple pituitary hormone deficiency [MPHD]), MRI magnet, geographical region, and cutoff serum growth hormone (GH) level. RESULTS: The pooled proportion of sellar and parasellar abnormalities was 58.0% (95% CI, 47.1-68.6%; I2, 98.2%). The MPHD group showed a higher proportion of sellar and parasellar abnormalities and pituitary stalk interruption syndrome than the IGHD group (91.4% vs. 40.1%, P<0.001; 65.3% vs. 20.1%, P<0.001). The patients in studies with low peak GH levels on stimulation tests were more associated with severe MR abnormalities (cutoff GH ≤ 5 μg/l vs. cutoff GH = 10 μg/l; 72.8 % vs. 38.0%; P<0.001). CONCLUSION: The types and incidence of MRI abnormalities of the sellar region differ significantly between the IGHD and MPHD groups.
PURPOSE: To verify and integrate the prevalence and phenotype of abnormalities in the sellar region in patients with growth hormone deficiency (GHD) using MRI data. METHODS: We searched PubMed and EMBASE up to December 14, 2020. The inclusion criteria were as follows: (1) pediatric patients diagnosed with nonacquired GHD and (2) detailed data sufficient to assess the proportion of sellar and parasellar abnormalities on brain MRI scans. Finally, thirty-two studies with 39,060 children (mean or median age, 3.4-14.1 years) were included. The number and type of MRI findings from all included studies were pooled by two authors. The heterogeneity across studies was evaluated with the Q test or the inconsistency index (I2) statistic. Subgroup analyses were performed according to the type of GHD (isolated GHD [IGHD] vs. multiple pituitary hormone deficiency [MPHD]), MRI magnet, geographical region, and cutoff serum growth hormone (GH) level. RESULTS: The pooled proportion of sellar and parasellar abnormalities was 58.0% (95% CI, 47.1-68.6%; I2, 98.2%). The MPHD group showed a higher proportion of sellar and parasellar abnormalities and pituitary stalk interruption syndrome than the IGHD group (91.4% vs. 40.1%, P<0.001; 65.3% vs. 20.1%, P<0.001). The patients in studies with low peak GH levels on stimulation tests were more associated with severe MR abnormalities (cutoff GH ≤ 5 μg/l vs. cutoff GH = 10 μg/l; 72.8 % vs. 38.0%; P<0.001). CONCLUSION: The types and incidence of MRI abnormalities of the sellar region differ significantly between the IGHD and MPHD groups.
Authors: I Fujisawa; K Kikuchi; K Nishimura; K Togashi; K Itoh; S Noma; S Minami; T Sagoh; T Hiraoka; T Momoi Journal: Radiology Date: 1987-11 Impact factor: 11.105
Authors: Varsha S Jagtap; Shrikrishna V Acharya; Vijaya Sarathi; Anurag R Lila; Sweta R Budyal; Rajeev Kasaliwal; Shilpa S Sankhe; Tushar R Bandgar; Padmavathy S Menon; Nalini S Shah Journal: Pituitary Date: 2012-06 Impact factor: 4.107
Authors: Vaman V Khadilkar; Hemchand Krishna Prasad; Veena H Ekbote; Vaishakhi T Rustagi; Joshita Singh; Shashi A Chiplonkar; Anuradha V Khadilkar Journal: Indian J Pediatr Date: 2014-04-29 Impact factor: 1.967
Authors: Cheri Deal; Caroline Hasselmann; Roland W Pfäffle; Alan G Zimmermann; Charmian A Quigley; Christopher J Child; Elena P Shavrikova; Gordon B Cutler; Werner F Blum Journal: Horm Res Paediatr Date: 2013-05-16 Impact factor: 2.852